Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,252Revenue (TTM) $M1,352Net Margin (%)24.6Altman Z-Score3.8
Enterprise Value $M8,323EPS (TTM) $5.3Operating Margin %37.9Piotroski F-Score8
P/E(ttm)25.8Beneish M-Score-2.6Pre-tax Margin (%)32.7Higher ROA y-yY
Price/Book5.110-y EBITDA Growth Rate %--Quick Ratio3.1Cash flow > EarningsY
Price/Sales6.35-y EBITDA Growth Rate %36.9Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow15.8y-y EBITDA Growth Rate %21.5ROA % (ttm)9.8Higher Current Ratio y-yN
Dividend Yield %--PEG0.7ROE % (ttm)22.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M60.4ROIC % (ttm)20.9Gross Margin Increase y-yY

Gurus Latest Trades with JAZZ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JAZZJoel Greenblatt 2016-03-31 Add0.02%$112.72 - $140.56
($124.56)
$ 136.5710%Add 6.84%197,619
JAZZGeorge Soros 2016-03-31 Sold Out -0.01%$112.72 - $140.56
($124.56)
$ 136.5710%Sold Out0
JAZZKen Fisher 2016-03-31 Add$112.72 - $140.56
($124.56)
$ 136.5710%Add 4.84%1,949
JAZZNWQ Managers 2015-12-31 Sold Out -0.25%$121.94 - $150.45
($138.92)
$ 136.57-2%Sold Out0
JAZZJoel Greenblatt 2015-12-31 Add0.24%$121.94 - $150.45
($138.92)
$ 136.57-2%Add 620.48%184,961
JAZZGeorge Soros 2015-12-31 Buy 0.01%$121.94 - $150.45
($138.92)
$ 136.57-2%New holding3,200
JAZZKen Fisher 2015-12-31 Add$121.94 - $150.45
($138.67)
$ 136.57-2%Add 7.77%1,859
JAZZJoel Greenblatt 2015-09-30 Add0.03%$124.46 - $193.02
($172.53)
$ 136.57-21%Add 620.11%25,672
JAZZNWQ Managers 2015-09-30 Reduce-0.01%$124.46 - $193.02
($172.53)
$ 136.57-21%Reduce -2.34%123,720
JAZZKen Fisher 2015-09-30 Add$124.46 - $193.02
($172.53)
$ 136.57-21%Add 32.69%1,725
JAZZSteve Mandel 2015-06-30 Sold Out -0.17%$167.87 - $189.92
($179.49)
$ 136.57-24%Sold Out0
JAZZNWQ Managers 2015-06-30 Add0.15%$167.87 - $189.92
($179.49)
$ 136.57-24%Add 95.42%126,680
JAZZJoel Greenblatt 2015-06-30 Reduce-0.01%$167.87 - $189.92
($179.49)
$ 136.57-24%Reduce -67.22%3,565
JAZZSteve Mandel 2015-03-31 Reduce-1.12%$158.12 - $189.01
($171.62)
$ 136.57-20%Reduce -86.14%260,985
JAZZJoel Greenblatt 2015-03-31 Buy 0.01%$158.12 - $189.01
($171.62)
$ 136.57-20%New holding10,874
JAZZNWQ Managers 2015-03-31 Add$158.12 - $189.01
($171.62)
$ 136.57-20%Add 0.06%64,824
JAZZKen Fisher 2015-03-31 Buy $158.12 - $189.01
($171.62)
$ 136.57-20%New holding1,300
JAZZNWQ Managers 2014-12-31 Reduce-0.13%$142.72 - $183.03
($166.14)
$ 136.57-18%Reduce -53.29%64,783
JAZZSteve Mandel 2014-09-30 Reduce-0.17%$132.55 - $174.37
($153.67)
$ 136.57-11%Reduce -14.30%1,788,607
JAZZNWQ Managers 2014-09-30 Reduce-0.1%$132.55 - $174.37
($153.67)
$ 136.57-11%Reduce -32.97%138,705
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JAZZ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JAZZ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MILLER MICHAEL PATRICKSVP, US Commercial 2016-07-15Sell100$142.43-4.11view
Smith Karen L.Global Head of R&D and CMO 2016-07-13Buy580$143.63-4.92view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-06-15Sell100$149.64-8.73view
Smith Karen L.Global Head of R&D and CMO 2016-06-13Buy557$149.61-8.72view
Mulligan SeamusDirector 2016-05-24Sell27,968$150.29-9.13view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-05-16Sell100$145.2-5.94view
RIEDEL NORBERT GDirector 2016-05-16Sell644$145.2-5.94view
McSharry Heather AnnDirector 2016-05-16Sell697$145.2-5.94view
WILSON KAREN JSVP, Finance & PAO 2016-04-25Sell604$160-14.64view
MILLER MICHAEL PATRICKSVP, US Commercial 2016-04-15Sell100$145.79-6.32view

Quarterly/Annual Reports about JAZZ:

News about JAZZ:

Articles On GuruFocus.com
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 
Stocks Fisher Investments Has Bought for Past 2 Quarters May 03 2016 
Citigroup, Amgen Are Trading With Wide Margin of Safety Mar 30 2016 
Weekly Insider Sells Highlight: MHK, JAZZ, BMY, ZAYO Mar 23 2015 
Pharmaceutical Giant Merck Buys Cubist Pharma Dec 09 2014 
Growth Momentum Should Continue For This Pharmaceutical Company Nov 15 2014 
Jazz Pharmaceuticals: Growth Trajectory Can Continue In Future Sep 03 2014 
Weekly CFO Sells Highlight: Google Inc, Jazz Pharmaceuticals PLC, Jack in the Box Inc. Jun 30 2014 
Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
Weekly CFO Sells Highlight: Jazz Pharmaceuticals PLC, Carnival PLC, Juniper Networks Inc., Home Depo Mar 10 2014 

More From Other Websites
JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Other Events Jul 28 2016
Actinium Pharmaceuticals: Another Promising Name In The AML Space Jul 27 2016
Jazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9, 2016 Jul 25 2016
Jazz Pharmaceuticals to Report 2016 Second Quarter Financial Results on August 9, 2016 Jul 25 2016
What Is An Options Sweep? Jul 22 2016
Bulls Crowd Into Jazz Pharmaceuticals For Good Reason Jul 15 2016
Jazz Pharmaceuticals: How Much Return Potential Does It Have? Jul 15 2016
A Look at Celator’s Lead Drug Vyxeos Jul 14 2016
How Can Celator’s Portfolio Complement Jazz Pharmaceuticals? Jul 14 2016
A Look at Jazz Pharmaceuticals’ Celator Acquisition Deal Jul 13 2016
Why Did Jazz Fall after Celator Acquisition Announcement? Jul 13 2016
JAZZ PHARMACEUTICALS PLC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Jul 12 2016
Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares... Jul 12 2016
Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares... Jul 12 2016
Jazz Pharma (JAZZ) Stock Receives 'Outperform' Rating at BMO Capital Jun 29 2016
Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator... Jun 26 2016
Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator... Jun 26 2016
Five companies that could buy Ariad this year for as much as $2.9B Jun 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)